Chronic anxiolytic treatment: benefit and risk.
Marks
J
J
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D004992:Ethics, Medical; D006801:Humans; D011613:Psychotherapy; D012940:Social Problems; D019966:Substance-Related Disorders
D014151:Anti-Anxiety Agents